Literature DB >> 11302947

Some of the challenges in drug development for irritable bowel syndrome.

E A Mayer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11302947      PMCID： PMC1728279          DOI： 10.1136/gut.48.5.585

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  21 in total

Review 1.  Emerging disease model for functional gastrointestinal disorders.

Authors:  E A Mayer
Journal:  Am J Med       Date:  1999-11-08       Impact factor: 4.965

Review 2.  Towards an integrative model of irritable bowel syndrome.

Authors:  B D Naliboff; L Chang; J Munakata; E A Mayer
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

Review 3.  Somatostatin receptors in the central nervous system.

Authors:  M Schindler; P P Humphrey; P C Emson
Journal:  Prog Neurobiol       Date:  1996-09       Impact factor: 11.685

4.  The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.

Authors:  M Delvaux; D Louvel; E Lagier; B Scherrer; J L Abitbol; J Frexinos
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

5.  Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat.

Authors:  Bernd Heppelmann; Matthias Pawlak
Journal:  Pain       Date:  1997-12       Impact factor: 6.961

Review 6.  Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations.

Authors:  L Bueno; J Fioramonti; M Delvaux; J Frexinos
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

7.  Intrathecal octreotide for relief of intractable nonmalignant pain: 5-year experience with two cases.

Authors:  J A Paice; R D Penn; J S Kroin
Journal:  Neurosurgery       Date:  1996-01       Impact factor: 4.654

8.  Effects of kappa opioids in the inflamed rat colon.

Authors:  J N Sengupta; A Snider; X Su; G F Gebhart
Journal:  Pain       Date:  1999-02       Impact factor: 6.961

Review 9.  Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception.

Authors:  W E Whitehead; O S Palsson
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

10.  Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

Authors:  M Delvaux; D Louvel; J P Mamet; R Campos-Oriola; J Frexinos
Journal:  Aliment Pharmacol Ther       Date:  1998-09       Impact factor: 8.171
View more
  1 in total

1.  Differential chemosensory function and receptor expression of splanchnic and pelvic colonic afferents in mice.

Authors:  Stuart M Brierley; R Carter; W Jones; Linjing Xu; David R Robinson; Gareth A Hicks; G F Gebhart; L Ashley Blackshaw
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.